SMAD2 and ovarian carcinoma: Within the stromal compartment, immunomodulatory cancer-associated fibroblast subsets, including INHBA+ CAFs that enforce SMAD2-dependent PD-L1 expression and regulatory T-cell differentiation, exemplify TGF-β–linked suppressive circuits in advanced ovarian cancer.